Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
LLY Coverage
Event
Eli Lilly and Company (LLY) Lilly To Acquire Centessa Pharmaceuticals To Advance Treatments For Sleep-Wake Disorders
Mar 31, 2026
Event
Eli Lilly and Company (LLY) Phase 3b data presented at AAD Annual Meeting show Lilly’s Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
Mar 29, 2026
Event
Eli Lilly and Company (LLY) Lilly’s EBGLYSS (Lebrikizumab-Lbkz) Delivered Up To Four Years Of Durable Disease Control For Patients With Moderate-To-Severe Atopic Dermatitis
Mar 27, 2026
Transcript
Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript
Mar 10, 2026
News
Eli Lilly and Company (LLY) Surges 5.1% — Developing Story
Feb 23, 2026
News
Eli Lilly and Company (LLY) to acquire Orna Therapeutics
Feb 9, 2026
News
Key highlights from Eli Lilly’s (LLY) Q4 2025 earnings results
Feb 4, 2026
Transcript
Eli Lilly and Company (LLY) Q2 2025 Earnings Call Transcript
Jan 22, 2026